Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection

In our laboratory, we have developed a model of vaccination in mice with Trypanosoma rangeli, a non-pathogenic parasite that shares many antigens with Trypanosoma cruzi. The vaccinated mice were protected against infection with virulent T. cruzi. The goal of the present work was to study the protect...

Full description

Bibliographic Details
Main Authors: Beatriz Basso, Edgardo Moretti, Ricardo Fretes
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 2008-06-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762008000400010
_version_ 1797756865192394752
author Beatriz Basso
Edgardo Moretti
Ricardo Fretes
author_facet Beatriz Basso
Edgardo Moretti
Ricardo Fretes
author_sort Beatriz Basso
collection DOAJ
description In our laboratory, we have developed a model of vaccination in mice with Trypanosoma rangeli, a non-pathogenic parasite that shares many antigens with Trypanosoma cruzi. The vaccinated mice were protected against infection with virulent T. cruzi. The goal of the present work was to study the protective activity of strains of T. rangeli of different origin, with the aim of analysing whether this protective capacity is a common feature of T. rangeli. BALB/c mice were vaccinated with live or fixed epimastigotes of two T. rangeli strains, Choachi and SC-58. Vaccinated (VM) and control mice (CM) were infected with virulent T. cruzi, Tulahuen strain. The results showed that the levels of parasitemia of VM, vaccinated with the two strains of T. rangeli were significantly lower than those developed in CM. The survival rate of VM was higher than that CM. Histological studies revealed many amastigote nests and severe inflammatory infiltrates in the heart and skeletal muscles of CM, whereas in the VM only moderate lymphomonocytic infiltrates were detected. Altogether, the results of the present work as well as previous studies show that the antigens involved in the protection induced by T. rangeli are expressed in different strains of this parasite. These findings could prove useful in vaccine preparation.
first_indexed 2024-03-12T18:07:42Z
format Article
id doaj.art-bdb2f358e5004e4896bf4e983b01795e
institution Directory Open Access Journal
issn 0074-0276
1678-8060
language English
last_indexed 2024-03-12T18:07:42Z
publishDate 2008-06-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-bdb2f358e5004e4896bf4e983b01795e2023-08-02T09:28:07ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz0074-02761678-80602008-06-01103437037410.1590/S0074-02762008000400010Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infectionBeatriz BassoEdgardo MorettiRicardo FretesIn our laboratory, we have developed a model of vaccination in mice with Trypanosoma rangeli, a non-pathogenic parasite that shares many antigens with Trypanosoma cruzi. The vaccinated mice were protected against infection with virulent T. cruzi. The goal of the present work was to study the protective activity of strains of T. rangeli of different origin, with the aim of analysing whether this protective capacity is a common feature of T. rangeli. BALB/c mice were vaccinated with live or fixed epimastigotes of two T. rangeli strains, Choachi and SC-58. Vaccinated (VM) and control mice (CM) were infected with virulent T. cruzi, Tulahuen strain. The results showed that the levels of parasitemia of VM, vaccinated with the two strains of T. rangeli were significantly lower than those developed in CM. The survival rate of VM was higher than that CM. Histological studies revealed many amastigote nests and severe inflammatory infiltrates in the heart and skeletal muscles of CM, whereas in the VM only moderate lymphomonocytic infiltrates were detected. Altogether, the results of the present work as well as previous studies show that the antigens involved in the protection induced by T. rangeli are expressed in different strains of this parasite. These findings could prove useful in vaccine preparation.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762008000400010vaccinationChagas diseaseTrypanosoma rangeliTrypanosoma cruzi
spellingShingle Beatriz Basso
Edgardo Moretti
Ricardo Fretes
Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection
Memorias do Instituto Oswaldo Cruz
vaccination
Chagas disease
Trypanosoma rangeli
Trypanosoma cruzi
title Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection
title_full Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection
title_fullStr Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection
title_full_unstemmed Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection
title_short Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection
title_sort vaccination with epimastigotes of different strains of trypanosoma rangeli protects mice against trypanosoma cruzi infection
topic vaccination
Chagas disease
Trypanosoma rangeli
Trypanosoma cruzi
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762008000400010
work_keys_str_mv AT beatrizbasso vaccinationwithepimastigotesofdifferentstrainsoftrypanosomarangeliprotectsmiceagainsttrypanosomacruziinfection
AT edgardomoretti vaccinationwithepimastigotesofdifferentstrainsoftrypanosomarangeliprotectsmiceagainsttrypanosomacruziinfection
AT ricardofretes vaccinationwithepimastigotesofdifferentstrainsoftrypanosomarangeliprotectsmiceagainsttrypanosomacruziinfection